PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12133827-6	2002	On the other hand, the DNA topoisomerase II inhibitor, TAS-103, strongly induced promoter activity, and this effect was completely eradicated when a mutation was introduced into the Oct1-binding site.	6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one	55-62	solute carrier family 22 member 1	Homo sapiens	182-186	
12133827-7	2002	Treatment with TAS-103 increased the levels of both Sp1/Sp3 and Oct1 in nuclear extracts.	6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one	15-22	solute carrier family 22 member 1	Homo sapiens	64-68